D676-1321 Screening compound: 1-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-4-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine

D676-1321 Screening compound: 1-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-4-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine
D676-1321 Screening compound: 1-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-4-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound D676-1321
1-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-4-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D676-1321

Molecular Formula

C23H21FN6O3 (C23 H21 FN6 O3)

Compound Name

1-{[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl}-4-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine

IUPAC name

1-{[5-(4-fluorophenyl)-124-oxadiazol-3-yl]methyl}-4-[3-(5-methyl-124-oxadiazol-3-yl)benzoyl]piperazine

SMILES

Cc1nc(-c2cccc(C(N3CCN(Cc4noc(-c(cc5)ccc5F)n4)CC3)=O)c2)no1

InChI

InChI=1S/C23H21FN6O3/c1-15-25-21(28-32-15)17-3-2-4-18(13-17)23(31)30-11-9-29(10-12-30)14-20-26-22(33-27-20)16-5-7-19(24)8-6-16/h2-8,13H,9-12,14H2,1H3

InChI Key

YTKMWAILLQLSPS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27595718

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.46

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.820

Distribution Coefficient, logD

2.820

Water Solubility, LogSw

-3.07

Polar Surface Area

84.000

Acid Dissociation Constant (pKa)

28.54

Base Dissociation Constant (pKb)

2.03

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.10

D676-1321 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with D676-1321 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D676-1321?
Check Price and Availability of D676-1321, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D676-1321 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D676-1321
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D676-1321
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D676-1321 available by request